Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study

2019163 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Clinical Therapeutics

Volume 41, Issue 10, pp. 2041-2056.e5

Field-Weighted Citation Impact: 9.78